Related Experiment Video

Updated: May 13, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
05:33

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus

Published on: June 23, 2022

Diverse seizure presentation of acute Mycoplasma pneumoniae encephalitis resolving with immunotherapy

Dimitrios Arkilo1, Beth Pierce, Frank Ritter

  • 11Minnesota Epilepsy Group, St. Paul, MN, USA.

Journal of Child Neurology
|March 14, 2013
PubMed

Insights

Three children with new-onset seizures, refractory to antiepileptic drugs, recovered fully after immunotherapy. Mycoplasma pneumoniae infection was identified as a potential cause for these pediatric epilepsy cases.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Immunology

Background:

  • New-onset seizures in children can be challenging to manage, particularly when refractory to standard antiepileptic medications.
  • Identifying underlying causes, including infectious triggers, is crucial for effective treatment strategies in pediatric epilepsy.

Observation:

  • Three previously healthy children presented with new-onset, severe, and refractory seizures.
  • All patients exhibited serum immunoglobulin M positivity for Mycoplasma pneumoniae.
  • Symptoms included focal motor seizures, nonconvulsive seizures, and hallucinations.

Findings:

  • Aggressive management combining immunotherapy (intravenous steroids and immunoglobulin) with antiepileptic medications led to significant clinical improvement.
  • All three patients achieved virtually complete recovery and excellent seizure control.
  • Mycoplasma pneumoniae infection is implicated as a potential cause of new-onset refractory epilepsy in these pediatric cases.

Implications:

  • This case series suggests that Mycoplasma pneumoniae infection should be considered in the differential diagnosis of new-onset pediatric seizures.
  • Immunotherapy, alongside antiepileptic drugs, may be a highly effective treatment approach for seizure disorders associated with Mycoplasma pneumoniae.
  • Early and aggressive treatment can lead to favorable long-term outcomes in children presenting with severe, infection-associated epilepsy.

Keywords:
Mycoplasma pneumoniae encephalitisimmunotherapyseizures

More Related Videos

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...